Human immunodeficiency virus-infected macrophages produce soluble factors that cause histological and neurochemical alterations in cultured human brains.
Open Access
- 1 February 1991
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 87 (2), 503-512
- https://doi.org/10.1172/jci115024
Abstract
We wanted to establish an in vitro human model for AIDS-associated dementia and pursue the hypothesis that this disease process may be a result of soluble factors produced by HIV-infected macrophages. Human brain aggregates were prepared from nine different brain specimens, and were treated with supernatants from in vitro HIV-infected macrophages (SI), uninfected macrophages (SU), infected T cells, or macrophage-conditioned media from four AIDS patients. Seven of nine treated brains exposed to SI showed peripheral rarefaction after 1 wk of incubation that by ultrastructural analysis showed cytoplasmic vacuolation. Aggregates from two of three brain cultures treated with SI for 3 wk became smaller, an approximately 50% decrease in size. The degree of apparent toxicity in brains exposed to patient-derived macrophage supernatants paralleled the proportion of macrophages found to be expressing HIV p24. Ultrastructural abnormalities were not observed in brains treated with supernatants from HIV-infected T cells, uninfected macrophages, or LPS-activated macrophages. Levels of five neurotransmitter amino acids were decreased in comparison to the structural amino acid leucine. These findings suggest that HIV-infected macrophages, infected both in vitro as well as derived from AIDS patients' peripheral blood, produce factors that cause reproducible histochemical, ultrastructural, and functional abnormalities in human brain aggregates.This publication has 22 references indexed in Scilit:
- Release of interleukin 1 inhibitory activity (contra-IL-1) by human monocyte-derived macrophages infected with human immunodeficiency virus in vitro and in vivo.Journal of Clinical Investigation, 1988
- The AIDS Dementia ComplexThe Journal of Infectious Diseases, 1988
- Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptideNature, 1988
- A normal human brain cell aggregate model for neurobiological studiesJournal of Neuroscience Research, 1988
- Quantitative Immunocytofluorographic Analysis of CD4 Surface Antigen Expression and HIV Infection of Human Peripheral Blood Monocyte/MacrophagesAIDS Research and Human Retroviruses, 1987
- The AIDS dementia complex: II. NeuropathologyAnnals of Neurology, 1986
- Isolation of HTLV-III from Cerebrospinal Fluid and Neural Tissues of Patients with Neurologic Syndromes Related to the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1985
- HTLV-III Infection in Brains of Children and Adults with AIDS EncephalopathyScience, 1985
- Sequence Homology and Morphologic Similarity of HTLV-III and Visna Virus, a Pathogenic LentivirusScience, 1985
- Cyclic AMP Induction of the Myelin Enzyme 2′,3′‐Cyclic Nucleotide 3′‐Phosphohydrolase in Rat OligodendrocytesJournal of Neurochemistry, 1983